Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $0.23 +0.01 (+3.01%) Closing price 04:00 PM EasternExtended Trading$0.22 0.00 (-1.92%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance 5 Day Performance+7.21%1 Month Performance-19.87%3 Month Performance-35.68%6 Month Performance-72.33%Year-To-Date Performance-36.70%1 Year Performance-84.94% Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CYCC Stock Chart for Tuesday, April, 15, 2025 CYCC Chart by TradingViewRemove Ads Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/14/2025$0.24$0.22-6.82%$0.25$0.2297,377 shs$1.40 million04/11/2025$0.22$0.24+7.66%$0.24$0.22169,945 shs$1.50 million04/10/2025$0.23$0.22-2.20%$0.23$0.2126,709 shs$1.40 million04/09/2025$0.21$0.23+6.27%$0.23$0.20165,671 shs$1.43 million04/09/2025$0.21$0.23+6.27%$0.23$0.20165,671 shs$1.43 million04/08/2025$0.19$0.21+13.62%$0.22$0.20159,914 shs$1.34 million04/08/2025$0.19$0.21+13.62%$0.22$0.20159,914 shs$1.34 million04/07/2025$0.21$0.19-12.15%$0.21$0.17455,670 shs$1.18 million04/04/2025$0.23$0.21-6.96%$0.23$0.20206,468 shs$1.35 million04/03/2025$0.25$0.23-6.20%$0.25$0.23139,779 shs$1.45 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/02/2025$0.27$0.25-8.85%$0.27$0.22303,064 shs$1.54 million04/01/2025$0.28$0.27-3.65%$0.28$0.26333,750 shs$1.69 million03/31/2025$0.30$0.28-6.62%$0.30$0.27187,430 shs$1.76 million03/28/2025$0.31$0.30-2.22%$0.31$0.30110,820 shs$1.88 million03/27/2025$0.30$0.31+0.46%$0.32$0.3081,611 shs$1.92 million03/26/2025$0.30$0.30+1.47%$0.31$0.29209,836 shs$1.91 million03/25/2025$0.32$0.30-7.41%$0.33$0.30190,115 shs$1.89 million03/24/2025$0.32$0.32+1.25%$0.33$0.30232,371 shs$2.04 million03/21/2025$0.30$0.32+6.81%$0.32$0.29297,176 shs$2.01 million03/20/2025$0.30$0.30-0.13%$0.31$0.29161,481 shs$1.88 million03/19/2025$0.30$0.30-1.09%$0.31$0.2957,116 shs$1.89 million03/18/2025$0.30$0.30-0.49%$0.31$0.29105,535 shs$1.91 million03/17/2025$0.30$0.30+2.63%$0.31$0.3062,491 shs$1.92 million03/14/2025$0.30$0.30-2.17%$0.30$0.2992,544 shs$1.87 million Related Companies Soligenix Stock Chart Onconetix Stock Chart Klotho Neurosciences Stock Chart Aeterna Zentaris Stock Chart AEON Biopharma Stock Chart Avalon GloboCare Stock Chart Conduit Pharmaceuticals Stock Chart Clearmind Medicine Stock Chart Creative Medical Technology Stock Chart Oragenics Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYCC Stock Free CYCC Stock Alerts